1,2-bis(2-aminophenoxy)ethane-n,n,n',n'-tetraacetic acid has been researched along with Bladder Cancer in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eto, M; Hirata, A; Inokuchi, J; Koga, H; Masuda, K; Naito, S; Okumura, K; Tatsugami, K; Tsunoda, T; Yokomizo, A | 1 |
1 other study(ies) available for 1,2-bis(2-aminophenoxy)ethane-n,n,n',n'-tetraacetic acid and Bladder Cancer
Article | Year |
---|---|
Inositol 1,4,5-trisphosphate (IP3) receptor type1 (IP3R1) modulates the acquisition of cisplatin resistance in bladder cancer cell lines.
Topics: Antineoplastic Agents; Apoptosis; Calcium; Calcium Channels; Cell Line, Tumor; Chelating Agents; Cisplatin; Cross-Linking Reagents; Down-Regulation; Drug Resistance, Neoplasm; Egtazic Acid; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Inositol 1,4,5-Trisphosphate Receptors; Oligonucleotide Array Sequence Analysis; Poly(ADP-ribose) Polymerases; Receptors, Cytoplasmic and Nuclear; RNA, Small Interfering; Urinary Bladder Neoplasms | 2005 |